新冠疫情期间眼科期刊中的循证医学
Evidence-Based Medicine in Ophthalmic Journals During Covid-19 Pandemic.
作者信息
Walter Eyal, Saban Ori, Jotkowitz Alan, Batash Tomer, Levy Jaime
机构信息
Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Department of Internal Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
出版信息
Clin Ophthalmol. 2020 Dec 14;14:4369-4372. doi: 10.2147/OPTH.S279013. eCollection 2020.
BACKGROUND
COVID-19 has erupted into our lives and forced rapid changes in all fields of medicine, causing a rush for publications that inevitably caused a shift away from the paradigm of evidence-based medicine (EBM). The objective of the present report is to assess and quantify this process.
METHODS
We compared the levels of EBM of the publications in the ophthalmic literature on COVID-19 at the beginning of the pandemic and compared it to those of articles published the prior year during April 2019 for the three highest ranking journals in the field of comprehensive ophthalmology.
RESULTS
COVID-19 publications ranked significantly lower (p<0.001). Time between submission and acceptance was significantly shorter for the COVID-19 publications (p<0.001), and significantly more publications were accepted without revisions (P<0.001).
CONCLUSION
Though a shift away from EBM may be unavoidable in the early stages of a pandemic, we suggest that for the benefit of reliable information and informed decision-making, it is time to go back to EBM.
背景
新型冠状病毒肺炎已闯入我们的生活，迫使医学各个领域迅速发生变化，引发了论文发表热潮，这不可避免地导致了从循证医学（EBM）范式的转变。本报告的目的是评估和量化这一过程。
方法
我们比较了疫情初期眼科文献中关于新型冠状病毒肺炎的出版物的循证医学水平，并将其与2019年4月该领域排名前三的综合眼科期刊上一年发表的文章的循证医学水平进行了比较。
结果
新型冠状病毒肺炎相关出版物的排名显著较低（p<0.001）。新型冠状病毒肺炎相关出版物从投稿到接受的时间显著更短（p<0.001），且接受时无需修改的出版物显著更多（P<0.001）。
结论
虽然在疫情早期偏离循证医学可能不可避免，但我们建议，为了获得可靠信息并做出明智决策，现在是回归循证医学的时候了。
Zotero 插件